HRMY Harmony Biosciences Holdings, Inc.: institutional ownership and insider trading
350 funds reported holding $2.18B of Harmony Biosciences Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net sold $89.0M, with 48 new positions and 33 funds selling out; over the last 12 months insiders bought $0 and sold $5.95M on the open market.
Famous investors holding HRMY
- Renaissance Technologies (Renaissance Technologies): $43.5M, 0.1% of the portfolio
- Ray Dalio (Bridgewater Associates): $9.05M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $34.9M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $11.6M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $11.6M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.93M, 0.0% of the portfolio
Largest institutional holders of HRMY
- BlackRock, Inc. (BLK) — $259M
- VANGUARD GROUP INC — $180M
- FMR LLC — $130M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $105M
- AMERICAN CENTURY COMPANIES INC — $92.5M
- DIMENSIONAL FUND ADVISORS LP — $87.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $76.6M
- LSV ASSET MANAGEMENT — $75.1M
- STATE STREET CORP (STT, STT-PG) — $67.7M
- ARMISTICE CAPITAL, LLC — $56.9M
Recent HRMY insider trades
- Sep 18, 2026: Budur Kumar sold 38,452 shares ($1.66M)
- Sep 8, 2026: Budur Kumar sold 33,954 shares ($1.45M)
- Jan 26, 2026: Kapadia Sandip sold 3,746 shares ($139K)
- Jan 15, 2026: Kapadia Sandip sold 20,961 shares ($753K)
5%+ owners
- BlackRock, Inc.: 11.3% (Schedule 13G/A, filed Jul 28, 2026)
- Vanguard Portfolio Management: 5.1% (Schedule 13G, filed Jul 31, 2026)